-Lapachone Micellar Nanotherapeutics for Non-Small Cell Lung Cancer Therapy

Cancer Research - United States
doi 10.1158/0008-5472.can-09-3995
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

New Strategies in Lung Cancer: Epigenetic Therapy for Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Advances in Immune Therapy for Non Small Cell Lung Cancer

Medical Diagnosis
2016English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

Adjuvant Therapy for Resected Non–Small-Cell Lung Cancer With Lymphovascular Invasion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

Non-Small Cell Lung Cancer

English

Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Shifting the Paradigm for Maintenance Therapy in Advanced Non-Small-Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

Oligometastatic Non-Small Cell Lung Cancer: Is There a Role for Locoregional Therapy?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Esterase-Activatable Β-Lapachone Prodrug Micelles for NQO1-targeted Lung Cancer Therapy

Journal of Controlled Release
Pharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy